|
| | 135270-13-2 Basic information |
| Product Name: | 135270-13-2 | | Synonyms: | 1-(((2R,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole;Efinaconazole Related Impurity 6;1-[[(2R,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-oxiranyl]methyl]-1H-1,2,4-triazole;Efinaconazole Epoxy Impurity;Efinaconazole Impurity 2;Efinaconazole Related Impurity;1H-1,2,4-Triazole, 1-[[(2R,3R)-2-(2,4-difluorophenyl)-3-methyl-2-oxiranyl]methyl]-;1-(((2R,3R)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole (Efinaconazole Impurity) | | CAS: | 135270-13-2 | | MF: | C12H11F2N3O | | MW: | 251.23 | | EINECS: | | | Product Categories: | | | Mol File: | 135270-13-2.mol |  |
| | 135270-13-2 Chemical Properties |
| Boiling point | 371.6±52.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 2.75±0.10(Predicted) |
| | 135270-13-2 Usage And Synthesis |
| Uses | (2R,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)methyl]oxirane is a useful synthetic intermediate in the synthesis of (2R,3S)-Efinaconazole (E435080); the 2R,3S-enantiomer of Efinaconazole (E435070) which is a topical antifungal for onychomycosis. |
| | 135270-13-2 Preparation Products And Raw materials |
|
